Probucol prevents blood–brain barrier dysfunction in wild‐type mice induced by saturated fat or cholesterol feeding
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: Dysfunction of the blood–brain barrier (BBB) is an early pathological feature of vascular dementia and A lzheimer's disease (AD) and is triggered by inflammatory stimuli. Probucol is a lipid‐lowering agent with potent anti‐oxidant properties once commonly used for the treatment of cardiovascular disease. Probucol therapy was found to stabilize cognitive symptoms in elderly AD patients, whereas in amyloid transgenic mice probucol was shown to attenuate amyloidosis. However, the mechanisms underlying the effects of probucol have note been determined. In the present study we investigated whether probucol can prevent BBB disturbances induced by chronic ingestion of proinflammatory diets enriched with either 20% (w/w) saturated fats (SFA) or 1% (w/w) cholesterol. Mice were fed the diets for 12 weeks before they were killed and BBB integrity was measured. Mice maintained on either the SFA‐ or cholesterol‐supplemented diets were found to have a 30‐ and sevenfold greater likelihood of BBB dysfunction, respectively, as determined by the parenchymal extravasation of plasma‐derived immunoglobulins and endogenous lipoprotein enrichment with β‐amyloid. In contrast, mice fed the SFA‐ or cholesterol‐enriched diets that also contained 1% (w/w) probucol showed no evidence of BBB disturbance. The parenchymal expression of glial fibrillary acidic protein, a marker of cerebrovascular inflammation, was significantly greater in mice fed the SFA‐enriched diet. Plasma lipid, β‐amyloid and apolipoprotein B levels were not increased by feeding of the SFA‐ or cholesterol‐enriched diets. However, mice fed the SFA‐ or cholesterol‐enriched diets did exhibit increased plasma non‐esterified fatty acid levels that were not reduced by probucol. The data suggest that probucol prevents disturbances of BBB induced by chronic ingestion of diets enriched in SFA or cholesterol by suppressing inflammatory pathways rather than by modulating plasma lipid homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Polyunsaturated fatty acid–cholesterol interactions: Domain formation in membranes
Wassall, S. R., & Stillwell, W. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.011 · Cited by 292
IgG Reactivity in the Spinal Cord and Motor Cortex in Amyotrophic Lateral Sclerosis
Engelhardt, J. I., & Appel, S. H. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530110068019 · Cited by 221
Meucci, G., Rossi, G., Bettini, R., Montanaro, D., Gironelli, L., Voci, L., & Bianchi, F. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90248-w · Cited by 26 · cited 1×
“Plasma proteins that are normally excluded from the brain parenchyma are found to increasingly penetrate as disease progresses, potentially creating a vicious inflammatory cycle.(4,5)”
Background
Cited by
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
Nelson, A. R., Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.016 · Cited by 559
Lipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
“When these mice were given probucol, which is the lipid-lowering agent, the non-esterified FA levels of plasma were increased and cerebrovascular inflammation or loss of BBB integrity didn’t occur, suggesting that probucol prevents disturbances of BBB induced by HFDs by suppressing inflammatory pathways rather than by…”
BackgroundElahy, M., Jackaman, C., Mamo, J. C., Lam, V., Dhaliwal, S. S., Giles, C., Nelson, D., & Takechi, R. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0029-9 · Cited by 300
Self-citationThe Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., et al. (2022) · Nutrients · doi:10.3390/nu14030668 · Cited by 225
Takechi, R., Lam, V., Brook, E., Giles, C., Fimognari, N., Mooranian, A., Al-Salami, H., Coulson, S. H., Nesbit, M., & Mamo, J. C. L. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00399 · Cited by 171
“D semi-quantitative microscopy was used to determine cerebral astrocyte activation and neurodegeneration by using GFAP and Fluoro-Jade C as described previously (Bian et al., 2007; Takechi et al., 2013b,c).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Takechi, R., Galloway, S., Pallebage‐Gamarallage, M. M., Lam, V., Dhaliwal, S. S., & Mamo, J. C.
- Venue
- Clinical and Experimental Pharmacology and Physiology
- Publisher
- Wiley
- Published
- 2012-12-23
- Volume
- 40
- Issue
- 1
- Pages
- 45-52
- ISSN
- 0305-1870 (ISSN-L)
- 1440-1681
- OpenAlex
- W2006938639
- Cited by
- 55
- References
- 4
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.